人体干细胞技术
Search documents
美儿简生物制品(上海)有限公司成立,注册资本500万人民币
Sou Hu Cai Jing· 2026-01-15 21:02
Core Viewpoint - Meierjian Biological Products (Shanghai) Co., Ltd. has been established with a registered capital of 5 million RMB, fully owned by Meierjian Biotechnology (Shanghai) Co., Ltd. [1] Company Information - The legal representative of Meierjian Biological Products (Shanghai) Co., Ltd. is Liu Bizuo [1] - The company is classified under the manufacturing industry, specifically in the chemical raw materials and chemical products manufacturing sector [1] - The registered address is located at No. 101, South District, 1st Floor, Building 1, 159 Cailun Road, China (Shanghai) Pilot Free Trade Zone [1] - The company type is a limited liability company (wholly foreign-owned enterprise) [1] - The business license allows for various activities including marine biological active substance extraction, purification, and synthesis technology research and development [1] Business Scope - The operational scope includes research and application of cell technology, manufacturing of specialized chemical products (excluding hazardous chemicals), medical research and experimental development, and development of human stem cell technology [1] - The company is also involved in human genetic diagnosis and treatment technology development, import and export of goods, and daily chemical product manufacturing [1] - Licensed projects include medical beauty services, life beauty services, and cosmetics production, which require approval from relevant authorities before commencement [1]
中蛇端粒再生健康科技(湖南)有限公司成立 注册资本500万人民币
Sou Hu Cai Jing· 2025-11-29 03:26
Group 1 - The establishment of Zhongshe Telomere Regeneration Health Technology (Hunan) Co., Ltd. has been officially registered with a capital of 5 million RMB [1] - The company is involved in various business activities including food sales, tea product production, and alcohol-related operations, which require specific approvals [1] - The general business scope includes health consulting services, cell technology research and application, and remote health management services among others [1] Group 2 - The company also engages in technology services, technical development, and marketing planning, indicating a diverse operational focus [1] - Additional activities include the sale of health food, biological feed research, and various retail services, showcasing a broad market approach [1] - The company is positioned to leverage artificial intelligence in industry applications, reflecting a modern technological integration [1]